When is an inducement 'undue'? Is a payment ever coercive?

September 2008
Clinical Trials Administrator;Sep2008, Vol. 6 Issue 9, p103
The article explains the reasons why payments to research participants are a significant issue to clinical research professionals. According to Neal Dickert, a resident at Johns Hopkins Hospital in Baltimore, Maryland, paying people too much money might invalidate their ability to give informed consent. He also argues that payments for research participation discourage potential participants from thinking carefully about the risks and benefits.


Related Articles

  • Hope goes on trial. Brink, Susan // U.S. News & World Report;1/14/2002, Vol. 132 Issue 1, p51 

    Discusses informed consent among participants of medical clinical trials. Confusion among participants who do not understand that experiments may not be designed to help them but to develop future treatments; How confusion results from a lack of information regarding the trial; Mention of...

  • Expert offers suggestions for standardizing subject payments.  // Clinical Trials Administrator;Sep2008, Vol. 6 Issue 9, p105 

    The article describes three models for how payments to research participants could be made. The models had been studied by Neal Dickert, a resident at Johns Hopkins Hospital in Baltimore, Maryland. According to the market model, participants would be paid according to the potential for benefit...

  • Stick to the statistics on risk in informed consent documents.  // Clinical Trials Administrator;May2009, Vol. 7 Issue 5, p58 

    This article explains that Yen-Hong Kuo, a biostatistician at the Jersey Shore University Medical Center in Neptune, New Jersey, is opposing the claim by Indepent Research Board (IRB) members, investigators and others that potential crinical trial participants will find hard data and numbers...

  • Assessment tool helps gauge consent abilities of Alzheimer's subjects.  // Clinical Trials Administrator;Sep2008, Vol. 6 Issue 9, p106 

    This article discusses research being done on the use of the MacArthur Competency Assessment Tool for Clinical Research (MacCAT-CR) to gauge consent abilities of people with Alzheimer's disease. It references a study published in the "American Journal of Geriatric Psychiatry" in 2008. The...

  • Should healthy volunteers in clinical trials be paid according to risk? Jones, Eleri; Liddell, Kathleen; Saunders, John // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;1/16/2010, Vol. 340 Issue 7738, p130 

    The authors claim that healthy volunteers in clinical trials should be paid according to risk. They pointed out that the action of volunteers is a gift to the society due to the higher risks in some clinical trials. They also think that this kind of voluntarism is inconsistent with other...

  • The Ethics of Research in Emergency Medicine. Biros, Michelle H. // Science & Engineering Ethics;Sep2007, Vol. 13 Issue 3, p279 

    The article comments on ethical issues that arise in emergency research. Researchers face difficulties in dealing with human subjects when doing research in emergency settings. Aside from the challenges encountered in designing and implementing studies that include critically ill patients, it is...

  • Start-up consultations improve site compliance.  // Medical Ethics Advisor;Feb2011, Vol. 27 Issue 2, p22 

    The article reports on start-up consultation, a study created to improve clinical trial site compliance in the U.S. It mentions that this type of consultation involves human subject research (HSR) regulatory experts who works with researchers to ensure that their documentation and consent...

  • Aging strategies call for 'reformed consent'  // IRB Advisor;Dec2009, Vol. 9 Issue 12, p142 

    The article calls for the reform of written informed consent (IC) forms used in clinical trial research involving human subjects. It suggests the presentation of IC document in a slide show accompanied by a narrative. Also recommended is the presentation of IC information in a way that would...

  • When to give the green light to placebo controls.  // IRB Advisor;Sep2009, Vol. 9 Issue 9, p102 

    The article presents several considerations for institutional review boards (IRBs) when considering studies that involve the use of placebo. Study participants should not be those in need of urgent treatment, such as patients with suicidal ideation or functional impairment. Informed consent...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics